Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Sales | 40 | 633 | 482 | 2 | 0 |
| Cost of Goods | 0 | 496 | 66 | 97 | N/A |
| Gross Profit | 40 | 137 | 416 | -96 | N/A |
| Operating Expenses | 12,211 | 11,417 | 5,551 | 3,431 | 0 |
| Operating Income | -12,171 | -10,785 | -5,069 | -3,429 | N/A |
| Interest Expense | 0 | 0 | 12 | 18 | 0 |
| Other Income | 0 | 0 | 1 | 5 | 0 |
| Pre-tax Income | -12,171 | -10,785 | -5,080 | -3,442 | 0 |
| Net Income Continuous | -12,171 | -10,785 | -5,080 | -3,442 | N/A |
| Net Income Discontinuous | -2,487 | N/A | N/A | N/A | N/A |
| Net Income | $-14,658 | $-10,785 | $-5,080 | $-3,442 | $N/A |
| EPS Basic Total Ops | -109.79 | -125.99 | -73.79 | -68.39 | N/A |
| EPS Basic Continuous Ops | -91.79 | -125.36 | -73.42 | -67.95 | N/A |
| EPS Basic Discontinuous Ops | -18.00 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -109.79 | -125.99 | -73.79 | -68.39 | N/A |
| EPS Diluted Continuous Ops | -91.79 | -125.36 | -73.42 | -67.95 | N/A |
| EPS Diluted Discontinuous Ops | -18.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-11,691 | $-10,312 | $-4,939 | $-3,414 | $N/A |